Adakveo (Crizanlizumab-tmca)
- Medicine Name: Adakveo
- Generic Name: Crizanlizumab-tmca
- Dosage Form & Strength: Injection: 100 mg/10 mL solution in a single-dose vial
- Manufactured By: Novartis
Medical Uses
Adakveo is a selectin blocker used in adults and pediatric patients aged 16 years and older who have sickle cell disease (SCD) to help scale down how often painful crises happen.
Recommended Dosage: The recommended dosage of Adakveo injection is 5 mg per kg administered by intravenous (IV) infusion over a time span of 30 minutes at Week 0th, week 2nd, and every 4th week thereafter.
In case a dose is skipped or missed, administer this medication as quickly as possible. If it is administered within 14 days after the skipped/missed dose, continue dosing as per the patient’s standard schedule. In case this medication is administered beyond 14 days after the skipped or missed dose, continue dosing every 28 days (4 weeks) thereafter. Adakveo may be given either with or without hydroxyurea.
Warning & Precautions
- Infusion-related reactions may occur in those taking treatment with Adakveo 100 mg/10 mL (10 mg/mL). Patients should be monitored for infusion-related reactions. Discontinue therapy with Adakveo infusion for serious reactions and institute apt medical care.
- Interference with automated platelet counts (platelet clumping) may occur following the use of Adakveo 100 mg injection, specifically when blood samples are gathered in tubes that contain EDTA (ethylenediaminetetraacetic acid). Mitigation strategies may be recommended.
- Crizanlizumab can cause fetal loss if administered to a pregnant woman. From a precautionary perspective, it is advised to avoid the use of Adakveo (crizanlizumab) Injection during pregnancy and in those females of childbearing age who do not consider contraception.
- Adakveo 100 mg/10 mL (10 mg/mL) solution may have a minimal influence on the potential to drive and use machines. Fatigue, dizziness, and somnolence may occur after the administration of Crizanlizumab.
Documentation & Availability
What documents are required to import ADAKVEO® to India?
ADAKVEO® (crizanlizumab-tmca) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is ADAKVEO® available in India?
ADAKVEO® (crizanlizumab injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input
- On availability of Adakveo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ADAKVEO® can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of ADAKVEO® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Adakveo injection price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the ADAKVEO® (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Adakveo®?
Crizanlizumab-tmca is a Generic Name for the trade name drug Adakveo®.
What is the Manufacturer’s Name of Adakveo®?
Adakveo® is manufactured by Novartis Pharmaceuticals Corporation.
Is Adakveo® approved by the FDA?
Yes, Adakveo® is approved by the FDA. Date of first/initial approval: November 15, 2019.
Where can I get Adakveo® at the best price in India?
To get the best Adakveo price in India, kindly get in touch with S S Healthcare (a WHO GDP and ISO 9001:2008 certified company). For Adakveo®, a valid medical prescription is required from a treating physician.
What is the dosage and form of Adakveo® supplied?
Adakveo® is supplied in the form of an Injection: 100 mg/10 mL solution in a single-dose vial for IV or intravenous administration.
What are the most common side effects of Adakveo®?
The most common side effects of Adakveo® are nausea, back pain, arthralgia, and pyrexia.
How much does Adakveo® cost in India?
The cost of Adakveo in India can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Adakveo®?
Store and transport refrigerated at 2-8°C (36-46°F) in the original carton to protect from light. Neither shake nor freeze it.
Is it safe to buy Adakveo® online in India?
Yes, one can buy Adakveo in India at the best price from the S S Healthcare if Adakveo is not registered or is unavailable in the respective country. We can facilitate the Import of Adakveo 100 mg injection through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
